The Journal of Practical Medicine >
Research progress on the role of bile acids in alcoholic liver disease
Received date: 2024-01-12
Online published: 2024-07-30
Alcoholic liver disease is liver disease caused by heavy and/or chronic alcohol consumption. Bile acids are synthesized in the liver and regulate the body through liver-intestinal circulation. Many studies have shown that bile acid is closely related to alcoholic liver disease. Alcohol intake can cause liver damage by affecting bile acid synthesis， hepato-enteric circulation and intestinal flora. This article summarizes the mechanism of action of bile acids in alcoholic liver disease and the current research status of improving alcoholic liver disease based on bile acid regulation， in order to provide new ideas for future research on the prevention and treatment of alcoholic liver disease.
Nan LI , Xue ZHAO , A′nali , Heran LIANG , Na. GE . Research progress on the role of bile acids in alcoholic liver disease[J]. The Journal of Practical Medicine, 2024 , 40(15) : 2187 -2193 . DOI: 10.3969/j.issn.1006-5725.2024.15.025
| 1 | HOSSEINI N， SHOR J， SZABO G. Alcoholic hepatitis： A review［J］. Alcohol Alcohol， 2019， 5（4）：408-416. doi:10.1093/alcalc/agz036 |
| 2 | SINGAL A K， BATALLER R， AHN J， et al. ACG clinical guideline： alcoholic liver disease［J］. Am J Gastroenterol， 2018， 113（2）：175-194. doi:10.1038/ajg.2017.469 |
| 3 | RUMGAY H， SHIELD K， CHARVAT H， et al. Global burden of cancer in 2020 attributable to alcohol consumption： a population-based study［J］. Lancet Oncol， 2021， 22（8）：1071-1080. doi:10.1016/s1470-2045(21)00279-5 |
| 4 | MéNDEZ-SáNCHEZ N， VALENCIA-RODRIGUEZ A， VERA-BARAJAS A， et al. The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer［J］. Hepatoma Res， 2020， 6：5. doi:10.20517/2394-5079.2019.29 |
| 5 | HYUN J， HAN J， LEE C， et al. Pathophysiological aspects of alcohol metabolism in the liver［J］. Int J Mol Sci， 2021， 22（11）：5717. doi:10.3390/ijms22115717 |
| 6 | MANLEY S， DING W. Role of farnesoid X receptor and bile acids in alcoholic liver disease［J］. Acta Pharm Sin B， 2015， 5（2）：158-167. doi:10.1016/j.apsb.2014.12.011 |
| 7 | 张召英，马春红. 胆汁酸在肝肠疾病中的免疫调节作用［J］. 山东大学学报（医学版）， 2021， 59（9）：30-36. |
| 8 | 熊淑琪. 胆汁酸生理功能及其与肠道微生物互作研究进展［J/OL］. 生物技术通报， 2023，39（4）：187-200. |
| 9 | GE M X， SHAO R G， HE H W. Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase［J］. Biochem Pharmacol， 2019， 164：152-164. doi:10.1016/j.bcp.2019.04.008 |
| 10 | CHIANG J Y L， FERRELL J M. Bile acids as metabolicregulators and nutrient sensors［J］. Annu Rev Nutr， 2019， 39：175-200. doi:10.1146/annurev-nutr-082018-124344 |
| 11 | JIA W， WEI M， RAJANI C， et al. Targeting the alternative bile acid synthetic pathway for metabolic diseases［J］. Protein Cell， 2021， 12（5）：411-425. doi:10.1007/s13238-020-00804-9 |
| 12 | DI CIAULA A， GARRUTI G， LUNARDI BACCETTO R， et al. Bile acid physiology［J］. Ann Hepatol， 2017， 16（Suppl. 1： s3-105）：s4-s14. |
| 13 | CHIANG J Y L， FERRELL J M. Bile acid metabolism in liver pathobiology［J］. Gene Expr， 2018， 18（2）：71-87. doi:10.3727/105221618x15156018385515 |
| 14 | CHIANG J Y， PATHAK P， LIU H， et al. Intestinal farnesoid Xreceptor and takeda G protein couple receptor 5 signaling in metabolic regulation［J］. Dig Dis， 2017， 35（3）：241-245. doi:10.1159/000450981 |
| 15 | POLAND J C， FLYNN C R. Bile acids， their receptors， and the gut microbiota［J］. Physiology （Bethesda）， 2021， 36（4）：235-245. doi:10.1152/physiol.00028.2020 |
| 16 | SPAHR L， RUBBIA-BRANDT L， GENEVAY M， et al. Early liver biopsy， intraparenchymal cholestasis， and prognosis in patients with alcoholic steatohepatitis［J］. BMC Gastroenterol， 2011， 11：115. doi:10.1186/1471-230x-11-115 |
| 17 | LI M， CAI S Y， BOYER J L. Mechanisms of bile acid mediated inflammation in the liver［J］. Mol Aspects Med， 2017， 56：45-53. doi:10.1016/j.mam.2017.06.001 |
| 18 | WOOLBRIGHT B L， JAESCHKE H. Novel insight into mechanisms of cholestatic liver injury［J］. World J Gastroenterol， 2012， 18（36）：4985-4993. doi:10.3748/wjg.v18.i36.4985 |
| 19 | XIE G， ZHONG W， LI H， et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption［J］. FASEB J， 2013， 27（9）：3583-3593. doi:10.1096/fj.13-231860 |
| 20 | ADACHI T， KAMINAGA T， YASUDA H， et al. The involvement of endoplasmic reticulum stress in bile acid-induced hepatocellular injury［J］. J Clin Biochem Nutr， 2014， 54（2）：129-135. doi:10.3164/jcbn.13-46 |
| 21 | YANG J S， KIM J T， JEON J， et al. Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice［J］. PLoS One， 201， 5（11）：e13858. doi:10.1371/journal.pone.0013858 |
| 22 | SCHOEMAKER M H， GOMMANS W M， CONDE DE LA ROSA L， et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation［J］. J Hepatol， 2003， 39（2）：153-161. doi:10.1016/s0168-8278(03)00214-9 |
| 23 | LIU Y， LIU T， ZHAO X， et al. New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease［J］. Cell Mol Life Sci， 2022， 79（9）：486. doi:10.1007/s00018-022-04509-6 |
| 24 | GONG X， ZHANG Q， RUAN Y， et al. Chronic alcohol consumption increased bile acid levels in enterohepatic circulation and reduced efficacy of irinotecan［J］. Alcohol Alcohol， 2020， 55（3）：264-277. doi:10.1093/alcalc/agaa005 |
| 25 | KIM Y D， HWANG S L， LEE E J， et al. Melatonin ameliorates alcohol-induced bile acid synthesis by enhancing miR-497 expression［J］. J Pineal Res， 2017， 62（2）. doi：10.1111/jpi.12386 . |
| 26 | KYRITSI K， WU N， ZHOU T， et al. Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity［J］. Cell Biosci， 2023， 13（1）：5. doi:10.1186/s13578-022-00945-w |
| 27 | DONEPUDI A C， FERRELL J M， BOEHME S， et al. Deficiency of cholesterol 7α-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice［J］. Hepatol Commun， 2017， 2（1）：99-112. doi:10.1002/hep4.1129 |
| 28 | 段晓延，扈金萍.胆汁酸转运体与相关疾病及药物研发进展［J］.药学学报， 2022， 57（12）：3576-3586. |
| 29 | CHEN W， ZHANG Q， DING M， et al. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression［J］. Chem Biol Interact， 2022， 356：109847. doi:10.1016/j.cbi.2022.109847 |
| 30 | MATYE D J， LI Y， CHEN C， et al. Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice［J］. Alcohol Clin Exp Res， 2021， 45（6）：1188-1199. doi:10.1111/acer.14619 |
| 31 | RIDLON J M， KANG D J， HYLEMON P B， et al. Gut microbiota， cirrhosis， and alcohol regulate bile acid metabolism in the gut［J］. Dig Dis， 2015， 33（3）：338-345. doi:10.1159/000371678 |
| 32 | CHIANG J Y L， FERRELL J M. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy［J］. Am J Physiol Gastrointest Liver Physiol， 2020， 318（3）：G554-G573. doi:10.1152/ajpgi.00223.2019 |
| 33 | JIANG L， ZHANG H， XIAO D， et al. Farnesoid X receptor （FXR）： structures and ligands［J］. Comput Struct Biotechnol J， 2021， 19：2148-2159. doi:10.1016/j.csbj.2022.02.029 |
| 34 | GADALETA R M， GARCIA-IRIGOYEN O， CARIELLO M， et al. Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor［J］. EBio Medicine， 2020， 54：102719. doi:10.1016/j.ebiom.2020.102719 |
| 35 | 孙悦，张文龙，李楠，等. 沙棘熊果酸对酒精性肝损伤大鼠肝FXR信号通路的影响［J］. 食品工业科技， 2023， 44（5）：363-370. |
| 36 | HARTMANN P， HOCHRATH K， HORVATH A， et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice［J］. Hepatology， 2018， 67（6）：2150-2166. doi:10.1002/hep.29676 |
| 37 | HUANG M， KONG B， ZHANG M， et al. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency［J］. Lab Invest， 2020， 100（9）：1158-1168. doi:10.1038/s41374-020-0439-y |
| 38 | KONG B， ZHANG M， HUANG M， et al. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury［J］. Dig Liver Dis， 2019， 51（4）：570-576. doi:10.1016/j.dld.2018.12.026 |
| 39 | TAKAHASHI S， TANAKA N， GOLLA S， et al. Editor's highlight： farnesoid X receptor protects against low-dose carbon tetrachloride-induced liver injury through the taurocholate-JNK pathway［J］. Toxicol Sci， 2017， 158（2）：334-346. doi:10.1093/toxsci/kfx094 |
| 40 | ALLEN K， JAESCHKE H， COPPLE B L. Bile acids induce inflammatory genes in hepatocytes： a novel mechanism of inflammation during obstructive cholestasis［J］. Am J Pathol， 2011， 178（1）：175-186. doi:10.1016/j.ajpath.2010.11.026 |
| 41 | WU W B， CHEN Y Y， ZHU B， et al. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice［J］. Biochimie， 2015， 115：86-92. doi:10.1016/j.biochi.2015.05.014 |
| 42 | REICH M， KLINDT C， DEUTSCHMANN K， et al. Role of the G protein-coupled bile acid receptor TGR5 in liver damage［J］. Dig Dis， 2017， 35（3）：235-240. doi:10.1159/000450917 |
| 43 | MERLEN G， BIDAULT-JOURDAINNE V， KAHALE N， et al. Hepatoprotective impact of the bile acid receptor TGR5［J］. Liver Int， 2020， 40（5）：1005-1015. doi:10.1111/liv.14427 |
| 44 | FAN M， WANG Y， JIN L， et al. Bile acid-mediated activation of brown fat protects from alcohol-induced steatosis and liver injury in mice［J］. Cell Mol Gastroenterol Hepatol， 2022， 13（3）：809-826. doi:10.1016/j.jcmgh.2021.12.001 |
| 45 | SPATZ M， CIOCAN D， MERLEN G， et al. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis［J］. JHEP Rep， 2021， 3（2）：100230. doi:10.1016/j.jhepr.2021.100230 |
| 46 | WINSTON J A， THERIOT C M. Diversification of host bile acids by members of the gut microbiota［J］. Gut Microbes， 2020， 11（2）：158-171. doi:10.1080/19490976.2019.1674124 |
| 47 | 于爽，顾志敏，樊亚东，等. 胆汁酸免疫调节作用及其与肠道、肝脏炎症性疾病相关性的研究进展［J］. 中国免疫学杂志， 2022， 38（16）：2031-2036. |
| 48 | GUO X， OKPARA E S， HU W， et al. Interactive relationships between intestinal flora and bile acids［J］. Int J Mol Sci， 2022， 23（15）：8343. doi:10.3390/ijms23158343 |
| 49 | MERONI M， LONGO M， DONGIOVANNI P. Alcohol or gut microbiota： who is the guilty？［J］. Int J Mol Sci， 2019， 20（18）：4568. doi:10.3390/ijms20184568 |
| 50 | CIOCAN D， VOICAN C S， WRZOSEK L， et al. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis［J］. Aliment Pharmacol Ther， 2018， 48（9）：961-974. doi:10.1111/apt.14949 |
| 51 | BAJAJ J S， KAKIYAMA G， ZHAO D， et al. Continued alcohol misuse in human cirrhosis is associated with an Impaired gut-liver axis［J］. Alcohol Clin Exp Res， 2017， 41（11）：1857-1865. doi:10.1111/acer.13498 |
| 52 | YU X， XUE M， LIU Y， et al. Effect of nicotinamide riboside on lipid metabolism and gut microflora-bile acid axis in alcohol-exposed mice［J］. Food Sci Nutr， 2020， 9（1）：429-440. doi:10.1002/fsn3.2007 |
| 53 | JIANG M， LI F， LIU Y， et al. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation［J］. Hepatology， 2023， 77（4）：1164-1180. doi:10.1002/hep.32608 |
| 54 | DUSZKA K. Versatile Triad Alliance： bile acid， taurine and microbiota［J］. Cells， 2022， 11（15）：2337. doi:10.3390/cells11152337 |
| 55 | LIN C J， CHIU C C， CHEN Y C， et al. Taurine attenuates hepatic inflammation in chronic alcohol-fed rats through inhibition of TLR4/MyD88 signaling［J］. J Med Food， 2015， 18（12）：1291-1298. doi:10.1089/jmf.2014.3408 |
| 56 | IRACHETA-VELLVE A， CALENDA C D， PETRASEK J， et al. FXR and TGR5 agonists ameliorate liver injury， steatosis， and inflammation after binge or prolonged alcohol feeding in mice［J］. Hepatol Commun， 2018， 2（11）：1379-1391. doi:10.1002/hep4.1256 |
| 57 | WU W， ZHU B， PENG X， et al. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease［J］. Biochem Biophys Res Commun， 2014， 443（1）：68-73. doi:10.1016/j.bbrc.2013.11.057 |
| 58 | 唐曼玉，王晚晴，强敬雯，等. 益生菌与肠道菌群、免疫调节的相互作用与机制研究进展［J］. 食品工业科技， 2022， 43（16）：486-493. |
| 59 | GU X， LU Q， ZHANG C， et al. Clinical application and progress of fecal microbiota transplantation in liver diseases： A Review［J］. Semin Liver Dis， 2021， 41（4）：495-506. doi:10.1055/s-0041-1732319 |
| 60 | CASSARD A M， CIOCAN D. Microbiota， a key player in alcoholic liver disease［J］. Clin Mol Hepatol， 2018， 24（2）：100-107. doi:10.3350/cmh.2017.0067 |
| 61 | CIOCAN D， SPATZ M， TRAINEL N， et al. Modulation of the bile acid enterohepatic cycle by intestinal microbiota alleviates alcohol liver disease［J］. Cells， 2022， 11（6）：968. doi:10.3390/cells11060968 |
| 62 | CAO Y J， HUANG Z R， YOU S Z， et al. The protective effects of ganoderic acids from ganoderma lucidum fruiting body on alcoholic liver injury and intestinalmicroflora disturbance in mice with excessive alcohol intake［J］. Foods， 2022， 11（7）：949. doi:10.3390/foods11070949 |
| 63 | LIU Y， CHEN K， LI F， et al. Probiotic lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice［J］. Hepatology， 2020， 71（6）：2050-2066. doi:10.1002/hep.30975 |
| 64 | FERRERE G， WRZOSEK L， CAILLEUX F， et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice［J］. J Hepatol， 2017， 66（4）：806-815. doi:10.1016/j.jhep.2016.11.008 |
/
| 〈 |
|
〉 |